Celebrate International Clinical Trials' Day, ECRIN Urges
ECRIN is encouraging all clinical researchers to get involved in International Clinical Trials' Day.
The European Clinical Research Infrastructure Network (ECRIN) is encouraging all clinical researchers to get involved in International Clinical Trials' Day (ICTD), which takes place today (May 20).
ICTD is designed to coincide with the day that the Scottish physician James Lind started his famous trial in 1747. He was a pioneer of naval hygiene, and by conducting the first ever clinical trial, he developed the theory that citrus fruits cured scurvy. The objective is to make May 20 a focal point for international communication events, meetings, debates, and celebrations of clinical research.
This will be followed on May 21 by a project meeting being organized by ECRIN, ECRAN (European Communication on Research Awareness Needs), ICTD and CRP (Clinical Research Program) in Luxembourg. This meeting aims to promote a transnational communication on multinational clinical trials with the objective of facilitating better clinical research relevant to the needs of patients and highlight the important role of patients in clinical research.
For further details, go to http://www.ecranproject.eu/en/content/communicate-clinical-research-two-days-two-great-event.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
